← Open Payments lookup

FARIBORZ SHAMS: Open Payments

NPI 1063421865 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,347 in 37 payments from 17 companies in 2025. Trend: 2023 $3,128 · 2024 $21,243 · 2025 $9,347

Consulting: $6,525Honoraria: $1,250Food & beverage: $1,151Travel & lodging: $421
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$6,264
Becton, Dickinson and Company2$2,250
Otsuka America Pharmaceutical, Inc.2$156
Janssen Biotech, Inc.1$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$77
ACADIA Pharmaceuticals Inc2$66
Lundbeck LLC3$57
Alkermes, Inc.2$45
AstraZeneca Pharmaceuticals LP2$43
Lilly USA, LLC2$40

Products named: INGREZZA, HemoSphere, RYBREVANT, CAPLYTA, REXULTI, JARDIANCE, ARISTADA, DAYBUE.

Industry payments across CA — which companies pay providers there.